AL-1095

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
AL-1095
AL-1095 structure.png
Clinical data
ATC code
  • none
Legal status
Legal status
  • In general: unscheduled
Identifiers
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC20H22ClNO
Molar mass327.139 g/mol g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

AL-1095,[1] developed by Aldrich[citation needed], is a centrally acting stimulant drug with comparable effects to amphetamine,[2] developed by Bristol in the 1970s.[3]

See also[edit]

References[edit]

  1. ^ US Patent 3506673 -2-(4'HALO)-BENZHYDRYL-3-QUINUCLIDINOLS
  2. ^ Hedblom, P.; Grinspoon, L. (1975). The Speed Culture: Amphetamine Use and Abuse in America. Cambridge: Harvard University Press. p. 50. ISBN 0-674-83192-6.
  3. ^ Warawa, E. J.; Mueller, N. J.; Gylys, J. A. (1975). "Quinuclidine Chemistry. 3. β-cis-2-(4'-Chlorobenzhydryl)-3-quinuclidinol, a New Central Nervous System Stimulant. Importance of the Benzhydryl Configuration". Journal of Medicinal Chemistry. 18 (1): 71–74. doi:10.1021/jm00235a016. PMID 803245.